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ABSTRACT 
Objective: Objective of the current investigation was to analyze effects of operating conditions on characteristics of nefopam hydrochloride 
nanospheres (NFH-NS). Statistical assessment and diagnostic analysis examined an adequacy and reliability of models.  
Methods: NFH-NS were developed by quasi solvent diffusion technique using poly (meth) acrylates by 35 Box-Behnken design. Drug: polymer ratio 
(X1), surfactant concentration (X2), stirring time (X3), DP/CP Ratio (X4) and stirring speed (X5) were selected as independent variables. Response 
variables investigated were % entrapment efficiency (% EE), mean particle size, % process yield and % drug loading (% DL).  
Results: Standardized Pareto chart illustrated that X1 and X5 were important factors (p<0.05) affecting response parameters of nanospheres. 
Significant model F-value (p<0.05) and non-significant lack of fit F-value (p>0.05) epitomized an accuracy of data. Smaller value of predicted 
residual error sum of squares (PRESS) for regression models stipulated good fit of models. Diagnostic analysis proved normality of data and 
signified that actual values of response parameters were in agreement with predicted values. Graphical analysis concluded that X1, X2, X4 and X5 had 
the significant positive effect on % EE. X1 and X5 produced remarkable synergistic and antagonistic effect on mean particle size, respectively. X1 and 
X5 exhibited positive effect on % process yield. X1 produced significant antagonistic effect on % DL.  
Conclusion: Optimization report concluded that formulation prepared with 1:3 drug: polymer ratio (w/w), 2 % (w/v) surfactant, 3.8 h stirring 
time, 1:12 DP/CP ratio and 2000 rpm stirring speed was having highest desirability function of 0.920. Regression models indicated good fit of 
model, adequate model discrimination and concluded that models can be used to navigate design space. 
Keywords: Nefopam hydrochloride, Polyacrylate, Diagnostic analysis, Standardized Pareto chart, Desirability function. 
 
INTRODUCTION 
Drug delivery is an interdisciplinary field of investigation and is 
acquiring the consideration of pharmaceutical researchers [1]. 
Utmost drugs are constrained by their poor solubility, aggregation 
due to poor solubility, non-specific delivery, high toxicity, high 
dosage, in-vivo degradation and short circulating half-lives. 
Nowadays, the field of drug delivery is evolving promptly as 
researchers from diverse disciplines have joined into support to 
overcome the drugs ever expanding problems [2]. 
Nefopam hydrochloride is a non-opioid, non-steroidal, centrally 
acting analgesic drug having IUPAC name 5-methyl-1-phenyl-1, 3, 4, 
6-tetrahydro-2, 5-benzoxazocine hydrochloride [3, 4]. It is the drug 
of preference for the relief of chronic pain such as cancer pain, 
nociceptive pain, postoperative pain and neuropathic pain [5-7]. It 
goes through substantial hepatic pre-systemic metabolism 
proximately 83%±7, has oral bioavailability approximately 30-40% 
and an elimination half life of about 3-5 h. The adverse effects of the 
drug such as nausea, vomiting, dizziness and patient non-compliance 
limits its application [5, 7]. 
Design of experiments (DOE) has evolved as powerful, elegant and 
cost-effective statistical technique which yields more information 
from fewest runs. Experimental designs are helpful in finding the 
relative significance of various factors affecting the characteristics of 
formulation [8-10]. Prerequisite tools needed for DOE include 
statistical analysis by ANOVA, diagnostic analysis and response 
surface analysis [11]. The statistical validation involves assessment 
of statistical parameters such as model F-value, lack of fit F-value, 
correlation coefficient (R2), adjusted R-squared (R2Adj), predicted R-
squared (R2Pred), predicted residual error sum of squares (PRESS) 
and adequate precision (AP). Model F-value and lack of fit F-value 
checks for model significance. Correlation coefficient measures 
amount of variation about the mean. Adjusted R-squared estimates 
amount of variation about the mean adjusted for the number of 
parameters in model. Predicted R-squared enunciates the predictive 
capability of model. PRESS is the sum of squared differences 
between the experimental response and predicted response by 
regression model. PRESS validates how this particular model fits 
each point in the design. PRESS statistics can be used in the 
regression model selection. Adequate precision compares the range 
of predicted values at design points to the average prediction error 
and measures signal to noise ratio (S/N ratio) [12, 13]. 
Diagnostics statistics to ensure adequacy and reliability of models. 
The normal probability plot graphical technique has been used for 
assessing whether or not the residuals are approximately normally 
distributed and it should exhibit a strongly linear pattern [14, 15]. 
The absence of the points in lower and upper extremes of plot 
indicates that there are not any significant outliers relative to 
normal distribution. Residual is the difference between the 
predicted value and an actual value. Residuals have been vital to 
regression for checking the goodness of data fit in regression line 
and establishing the credibility of analysis. Studentized residual is 
the quotient resulting from division of a residual by an estimate of 
its standard deviation. The studentized residuals have importance in 
judging outliers in y-direction. Outlier is an observation with large 
residual. Externally studentized residual vs. predicted plot tests the 
assumption of constant variance [16, 17]. Externally studentized 
residual vs. run plot has been used for checking lurking variable that 
can influence the response during experiment [18]. Predicted vs. 
actual plots detects how well the model fits the data. For a perfect fit, 
all the points would be on diagonal [19, 20]. Response surface 
analysis graphically depicts mathematical relationship between 
independent and dependent variable in form of response surface 
plot or contour plot. 
Polyacrylate nanospheres of nefopam hydrochloride were prepared 
by quasi solvent diffusion technique using ratio of two different 
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grades of poly (meth) acrylates polymer with the quaternary 
ammonium group to get sustained release of drug [21]. Box-
Behnken design response surface methodology was used for design 
of experiments. The objective of the current investigation was to study 
effect of operating conditions on response parameters and statistical 
assessment of the results of experimental design to analyze 
significance and fitting of model. Diagnostic analysis was performed to 
check adequacy and reliability of models. Response surface graphical 
analysis was conducted to generate mathematical relationship in form 
of the contour plot (2-D) or response surface plot (3-D) between 
independent and dependent variable. Optimization report was 
developed by Design-Expert software for determining optimum 
formulation having the highest desirability function. 
MATERIALS AND METHOD 
Materials  
Nefopam hydrochloride (C17H20ClNO, 5-methyl-1-phenyl-1, 3, 4, 6-
tetrahydro-2, 5-benzoxazocine hydrochloride, Mw 289.8 g mol-1, CAS 
NO-23327-57-3, 99.57 % purity) was procured from Hangz Hou-
Daying-Chem. Company Ltd. China. Eudragit RL 100 and RS 100 
were received as a gift sample amiably supplied by Evonik 
Industries AG, Mumbai, India. Acetone (2-Propanone, C3H6O, Mw 
58.08 g mol-1), Heavy liquid paraffin, n-hexane (C6H14, Mw 86.18) 
and were obtained from Merck Specialties Private Limited, Mumbai. 
Span 80 (sorbitan monooleate, HLB-4.3), Magnesium Stearate 
(magnesium octadecanoate, 591.27 g mol-1), Sodium hydroxide, 
Potassium dihydrogen phosphate and Methanol were obtained from 
Loba Chemicals Private Limited, Mumbai, India. Petroleum ether 
was purchased from Thomas Bakers Chemical Private Limited, 
Mumbai. All other chemicals used were of analytical grade. 
Experimental design 
A 5-factor 3-level Box-Behnken design was established for design of 
experimentation [22, 23]. The independent and dependent variables 
used in design are listed in table 1. This study design of 46 
experimental runs was generated and analyzed by Design-Expert 
software (Trial Version 9.0.3.1, Stat-Ease Inc., MN). 
 
Table 1: Variables used in 5-factor 3-level Box-Behnken design using Design-Expert software trial version 9.0.3.1 
 Levels    
 Low Medium High 
Independent variables  
X1= Drug: polymer ratio (w/w) 1:2 1:3 1:4 
X2= Surfactant concentration (% w/v) 0.5 1 2 
X3= Stirring time (h) 2 3 4 
X4= DP/CP Ratio (v/v) 1:5 1:10 1:15 
X5= Stirring Speed (rpm) 1000 1500 2000 
Dependent variables Objective 
Y1= Entrapment Efficiency (% EE, w/w)   Maximize 
Y2= Mean Particle Size (nm)    Minimize 
Y3= Process yield (%, w/w)   Maximize 
Y4= Drug Loading (% DL, w/w)    Maximize 
 
Fabrication of nefopam hydrochloride loaded nanospheres  
Polyacrylate nanospheres of nefopam hydrochloride (F1-F46) were 
prepared by quasi solvent diffusion technique as previously 
revealed [24]. Accurate quantity of nefopam hydrochloride, eudragit 
RL 100 and RS 100 was dissolved in acetone-ethanol mixture (DP). 
Resultant mixture was extruded through syringe #20 slowly to 
heavy liquid paraffin (CP). Sorbitan monooleate and n-hexane was 
utilized as surfactant and hardening agent, respectively.  
The mixture was continuously stirred with magnetic stirrer (Remi 
Instruments Division, India) at 38±0.5o, centrifuged and washed 
with petroleum ether. Nanospheres were accumulated by filtration 
utilizing 0.22 μm membrane filters followed by ultracentrifugation 
at 20,000 rpm for 30 min applying cooling centrifuge (RIS-24 BL, 
Remi Instruments Division, and India) and freeze drying using 
lyophilizer (ISIC Make, India). A schematic representation of 
polyacrylate nanospheres of nefopam hydrochloride preparation 
has been illustrated in fig 1. 
 
 
Fig. 1: Schematic representation for fabrication of polyacrylate nanospheres loaded with nefopam hydrochloride 
Singh et al. 
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Determination of entrapment efficiency and drug loading  
50 mg polyacrylate nanospheres of nefopam hydrochloride (F1-F46) 
was accurately weighed and extracted with phosphate buffer, pH 7.4 
for 24 h followed by centrifugation at 3500 rpm for 10 min. 
Supernatant was assayed spectrophotometrically at 266 nm using 
double beam UV spectrophotometer (Systronics AU2701, India). 
Each measurement was taken in triplicate [25]. NFH concentration 
was estimated using the calibration curve. The drug entrapment 
efficiency (% EE, w/w) and drug loading (% DL, w/w) of each 
formulation of nanosphere was calculated according to Eq. (1) and 
Eq. (2), respectively. 
% 𝐸𝐸𝐸𝐸,𝑤𝑤/𝑤𝑤 = 𝑊𝑊𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸
𝑊𝑊𝐷𝐷𝐸𝐸𝐷𝐷𝐷𝐷  
× 100 Eq. (1) 
% 𝐷𝐷𝐷𝐷,𝑤𝑤/𝑤𝑤 = 𝑊𝑊𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸
𝑊𝑊𝐷𝐷𝐸𝐸𝐷𝐷𝐷𝐷 +𝑊𝑊𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝐸𝐸𝐸𝐸  
× 100 Eq. (2) 
Where, WEntrapped, WDrug and WPolymer were weight of drug entrapped, 
weight of drug and weight of polymer taken in the system, respectively. 
Light microscopy 
Mean particle size analysis of polyacrylate nanospheres of nefopam 
hydrochloride (F1-F46) was conducted under the light microscope 
with ×400 magnification (Adeltavision Microscopes, India). Images 
were taken with an APCAM USB2 digital cameras system (APCAM, 
India) and processed with the Adelta Optec’s AP View imaging 
software. A thin layer of the sample that has been previously diluted 
with distilled water was spread on microscope slide and viewed 
under microscope. Samples were measured in triplicate (n = 3) and 
an average value was proclaimed as mean particle size. 
Determination of process yield 
Weight of dried nanospheres recovered from each run (F1-F46) was 
weighed accurately. Process yield (% PY, w/w) of nanosphere was 
calculated using Eq. (3). 
% 𝑃𝑃𝑃𝑃,𝑤𝑤/𝑤𝑤 = 𝑊𝑊𝐷𝐷𝐸𝐸𝐷𝐷𝐸𝐸𝐸𝐸  𝐸𝐸𝐸𝐸𝐸𝐸𝑃𝑃𝑛𝑛𝐸𝐸 ℎ𝐸𝐸𝐸𝐸𝐸𝐸𝑛𝑛
𝑊𝑊𝐷𝐷𝐸𝐸𝐷𝐷𝐷𝐷 +𝑊𝑊𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝐸𝐸𝐸𝐸  
× 100 Eq. (3) 
Where, WDried nanospheres, WDrug and WPolymer were weight of dried 
nanospheres recovered, weight of drug and weight of polymer taken 
in the system, respectively. 
Analysis of experimental data by design-expert software 
Standardized pareto chart effect study 
The main effect of operating conditions on response parameters was 
depicted in standardized pareto chart. The length of each bar in 
chart was proportional to the standardized effect and would be 
utilized to test the statistical significance of that response 
parameter. The factors with p<0.05 appeared to be the main factors 
affecting response parameters. 
Statistical analysis 
Design-Expert software was used for statistical assessment of the 
results of experimental design that indulged eminent useful data and 
asserted the expediency of statistical design for conduct of 
experiments. The statistical validation was entrenched by 
assessment of statistical parameters such as model F-value, lack of 
fit F-value, correlation coefficient (R2), adjusted R-squared (R2Adj), 
predicted R-squared (R2Pred), predicted residual error sum of 
squares (PRESS) and adequate precision (AP) generated by ANOVA 
provision available in the Design-Expert software to check 
sufficiency and adequacy of models. Model F-value with p<0.05 and 
lack of fit F-value with p>0.05 for response variables implied that 
model was significant and the lack of fit was non-significant relative 
to the pure error, respectively. When the difference between R2Adj 
and R2Pred is less than 0.2, R2Pred would be in reasonable agreement 
with R2Adj. PRESS statistics were used for cross-validation to provide 
the measure of fit. Regression model with a smaller value of PRESS 
statistics was preferred. Adequate precision measured signal to 
noise ratio (S/N ratio). AP value greater than 4 indicated adequate 
model discrimination. Statistical parameters F-value, R2, R2Adj, R2Pred, 
PRESS and AP have been expressed in Eqs. (4)-(11) [26, 27]. 
Mean Square (MS) = Sum of Square
Degree of freedom
 Eq. (4) 
F = MSRegression
MSResidual
 Eq. (5) 
R2 = 1 − SSResidual
SSModel+SSResidual
 Eq. (6) 
RAdj2 = 1 −
SSResidual DFResidual⁄
(SSModel+SSResidual) (DFModel+DFResidual)⁄
 Eq. (7) 
RPred2 = 1 −
PRESS
SSModel+SSResidual
 Eq. (8) 
𝑅𝑅𝐸𝐸𝑛𝑛𝐷𝐷𝐸𝐸𝐷𝐷𝐸𝐸𝑃𝑃 = 𝐸𝐸𝐷𝐷 = [𝑃𝑃𝐷𝐷−ŷ𝐷𝐷  ] Eq. (9) 
𝑃𝑃𝑅𝑅𝐸𝐸𝑃𝑃𝑃𝑃 = � [𝐸𝐸𝐷𝐷]2
𝐸𝐸








 Eq. (11) 
Where, SS is sum of square; DF is degree of freedom; yi = predicted 
value; ŷi = actual value; PRESS is predicted residual error sum of 
squares; AP is adequate precision; p is the number of model 
parameters, σ2 residual mean square, and n is number of experiments. 
Diagnostic analysis 
Diagnostic plots such as normal probability plot, externally 
studentized residuals vs. predicted plot, externally studentized 
residuals vs. run plot and predicted vs. actual plot was developed by 
Design-Expert software. The normal probability plot was 
represented between normal % probability and externally 
studentized residual. Externally studentized residual vs. predicted 
plot was plotted between externally studentized residual and 
predicted values of the response parameters [18]. Externally 
studentized residual vs. run plot was graphically represented 
between externally studentized residual and order of the 
experimental run. Predicted vs. actual plots were delineated 
between predicted and actual response parameter values. 
Response surface analysis 
The response variables obtained by DoE trials as per study design 
were suitably modeled to generate graphical depiction of 
mathematical relationship between independent variables and 
dependent variable in the form of contour plot (2-D) and response 
surface graph (3-D) using Design-Expert software [28, 29]. 
Optimization 
Optimization report was developed by Design-Expert software for 
determining optimum formulation having highest desirability 
function (Myers et al., 2009).  
RESULTS AND DISCUSSION 
Standardized pareto chart effect study 
Standardized pareto chart effect study was conducted to discover 
the important factors affecting response parameters of nanospheres. 
The drug: polymer ratio (X1), surfactant concentration (X2) and 
DP/CP ratio (X4) had significant positive effect on % EE as revealed 
by statistical significant p-value (p<0.05) of regression coefficient as 
shown in standardized pareto chart in fig. 2a. Drug: polymer ratio 
(X1) and stirring speed (X5) exhibited significant synergistic and 
antagonistic effect on mean particle size, respectively (fig. 2b). Drug: 
polymer ratio (X1) and stirring speed (X5) had the significant 
synergistic effect on % PY (fig. 2c). Drug: polymer ratio (X1) 
manifested significant antagonistic effect on % DL. DP/CP ratio (X4) 
and stirring speed (X5) produced significant synergistic effect on % 
DL (fig. 2d). From the analysis, it was concluded that drug: polymer 
ratio (X1) and stirring speed (X5) was the important factors affecting 
response parameters of nanospheres. 
Statistical analysis 
Analysis of variance (ANOVA) was applied to % EE to study fitting 
and significance of the model. F-test was carried out to compare 
regression mean square with residual mean square. Model F-value 
and lack of fit F-value were found 12.44 (p<0.05) and 1.94 (p>0.05), 
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respectively which implied that model was significant and lack of fit 
was non-significant relative to pure error, epitomizing accuracy of 
data. Non-significant lack of fit indicated good fit of model. 
Therefore, estimated model may be used for % EE (table 2). 
Correlation coefficient was 0.9120 which indicated absence of 
variation about the mean.  
Difference between predicted R2 and adjusted R2was found less than 
0.2 which indicated rational agreement between regression 
coefficients. PRESS value was found 642.42 which revealed 
substantial fit of model. Adequate precision value was found 15.631 
which indicated an adequate signal and concluded that model can be 
used to navigate design space (table 3). 
 
 
Fig. 2: Standardized pareto chart for (a) % entrapment efficiency (b) mean particle size (c) % process yield and (d) % drug loading (* 
significant value p<0.05) 
 
Model generated for mean particle size was found significant as 
indicated by model F-value 13.71 (p<0.05). Data obtained for mean 
particle size was acceptable as revealed by non-significant lack of fit 
F-value 3.82 (p>0.05) (table 2). Predicted R2 value was found 0.6848 
which was in fair agreement with an adjusted R2 value of 0.8525. 
PRESS value for mean particle size was perceived 2.583E+005 which 
indicated considerable fit of model. An adequate precision value of 
16.739 for mean particle size specified fair the signal to noise ratio 
(S/N ratio>4) (table 3).  
Model generated for % process yield was found significant as 
indicated by model F-value 13.71 (p<0.05). "Lack of Fit F-value" of 
3.00 implied the lack of fit was not significant relative to the pure 
error (table 2). Predicted R2 value was found 0.6646 which was in 
rational agreement with an adjusted R2 value of 0.8525. PRESS value 
for % process yield was found 610.89 which indicated remarkable 
model fitting. "Adequate Precision" measured signal to noise ratio. 
S/N ratio was found 14.567 which indicated an adequate signal 
because ratio greater than 4 was required for adequate model 
discrimination (table 3). 
Model generated for % DL was found significant as indicated by 
model F-value 25.81 (p<0.05). "Lack of Fit F-value" of 1.84 implies 
lack of fit was not significant relative to the pure error (table 2). 
Predicted R2 value was found 0.8186 which was in fair agreement 
with an adjusted R2 value of 0.9186. PRESS value was found 38.42 
which indicated significant model fitting. S/N ratio was found 
20.384 which revealed an adequate signal (table 3). 
 
Table 2: ANOVA for (a) % entrapment efficiency (b) mean particle size (c) % process yield and (d) % drug loading 
Term Y1 Y2 Y3 Y4 
F-Value, p value F-Value, p-value F-Value, p-value F-Value, p-value 
Model 12.44,<0.0001* 13.71,<0.0001* 13.71,<0.0001* 25.81,<0.0001* 
X1 65.46,<0.0001* 148.31,<0.0001* 165.07,<0.0001* 382.43,<0.0001* 
X2 9.72, 0.0047* 0.68, 0.4184 0.036, 0.8507 10.15, 0.0040* 
X3 2.89, 0.1022 7.542, 0.9315 2.68, 0.1147 2.81, 0.1065 
X4 10.60, 0.0034* 0.53, 0.4744 2.02, 0.1678 11.46, 0.0024* 
X5 38.14,<0.0001* 54.94,<0.0001* 9.24, 0.0056* 40.10,<0.0001* 
X1X2 7.745, 0.9306 0.48, 0.4935 0.14, 0.7144 4.081, 0.9496 
X1X3 0.40, 0.5323 1.50, 0.2333 2.10, 0.1603 0.23, 0.6362 
X1X4 2.586, 0.9599 0.15, 0.6977 0.29, 0.5981 0.25, 0.6195 
X1X5 0.064, 0.8030 7.91, 0.0096* 1.86, 0.1853 0.054, 0.8188 
X2X3 1.33, 0.2599 0.31, 0.5835 0.038, 0.8476 1.38, 0.2520 
X2X4 3.217, 0.9552 2.09, 0.1609 1.71, 0.2035 4.081, 0.9496 
X2X5 4.957, 0.9445 1.19, 0.2868 0.070, 0.7932 5.165, 0.9433 
X3X4 0.013, 0.9106 1.42, 0.2443 2.69, 0.1138 0.014, 0.9057 
X3X5 1.56, 0.2242 0.17, 0.6826 4.15, 0.0528 1.63, 0.2136 
X4X5 0.96, 0.3370 1.166, 0.9730 0.28, 0.6023 1.01, 0.3244 
X12 92.74,<0.0001* 18.54, 0.0002* 27.28,<0.0001* 38.72,<0.0001* 
X22 0.49, 0.4895 0.042, 0.8389 31.69,<0.0001* 0.55, 0.4641 
X32 2.13, 0.1576 13.13, 0.0014* 0.33, 0.5722 2.48, 0.1282 
X42 25.02,<0.0001* 8.83, 0.0066* 0.16, 0.6958 27.70,<0.0001* 
X52 1.98, 0.1723 38.02,<0.0001* 0.25, 0.6189 1.47, 0.2366 
Lack of Fit 1.94, 0.2745 3.82, 0.1012 3.00, 0.1479 1.84, 0.2940 
*Significant value p<0.05 
Singh et al. 
Int J Pharm Pharm Sci, Vol 7, Issue 10, 89-101 
 
93 
Table 3: Model statistics of % EE (Y1), mean particle size (Y2), % PY (Y3) and % DL (Y4) 
Parameters Y1 Y2 Y3 Y4 
R2 0.9120 0.9195 0.9195 0.9556 
Adjusted R2 0.8387 0.8525 0.8525 0.9186 
Predicted R2 0.6397 0.6848 0.6646 0.8186 
PRESS 642.42 2.583E+005 610.89 38.42 
Adequate Precision 15.631 16.739 14.567 20.384 
 
Diagnostic analysis 
Diagnostic plots were plotted to investigate the goodness of fit of 
proposed model. Fig. 3a represented the normal probability plot of 
externally studentized residuals on probit scale which indicated that 
maximum number of color points depicting value of % EE was 
located on normal probability line which proved normality of 
residuals and suggested that response data provided relevant 
analysis. Normal probability plot indicated whether the residuals 
followed normal probability distribution [14]. Fig. 3b illustrated 
externally studentized residuals vs. predicted values revealed that 
color points delineating value of % EE were sited within the limits 
close to zero-axis which sighted the absence of constant error. Fig. 3c 
explored residual vs. run plot to look for influential variable that may 
have influenced % EE during the experiment [18]. Predicted vs. actual 
values plot depicted in fig. 3d revealed that graph was highly linear 
passing through origin which signified that experimentally observed 
values of % EE were in close agreement with predicted values [18, 20]. 
 
 
Fig. 3: Diagnostic plot for % entrapment efficiency (a) normal probability plot (b) studentized residuals vs. predicted values plot (c) 
externally studentized residuals vs. run number plot and (d) predicted vs. actual values plot 
 
Normal plot of studentized residuals represented in fig. 4a indicated 
that the maximum number of color points depicting mean particle 
size followed straight line when plotted on probit scale which 
indicated that response data need not any transformation [14]. Fig. 
4b illustrated studentized residuals vs. predicted values which 
revealed that all color points representing mean particle size had 
been scattered randomly and uniformly close to zero-axis and had 
constant range of residual across the graph which illustrated 
absence of constant variance. Residual versus order of the 
experimental run for mean particle size were graphically 
represented in fig. 4c. Random and uniform scatter of points 
explored absence of lurking variables for mean particle size. Actual 
vs. predicted plots were plotted between the actual and predicted 
values of mean particle size for detecting values that cannot be 
easily predicted by model. Straight line passing from origin revealed 
that experimentally observed values of mean particle size were 
analogous with predicted values (fig. 4d). 
Normal probability plot of the studentized residuals indicated that 
maximum number of color points corresponding to % process yield 
was detected on straight line which proved normality of response 
data (fig. 5a). Studentized residuals vs. predicted values plot 
revealed the absence of megaphone pattern which indicated 
suitability of % process yield data and absence of constant error (fig. 
5b). Fig. 5c explored residual vs. run plot showed random and 
uniform scatter of color points corresponding to % process yield 
[18]. Predicted vs. actual values plot revealed most pragmatic 
information of prognosis that the experimentally observed values of 
% process yield were analogous with those predicted using 
optimization methodology (fig. 5d). 
Normal probability plot indicated whether the residuals followed 
normal probability distribution. The maximum number of color 
points corresponding to % DL plotted on probit scale was sited on 
straight line as represented in fig. 6a.  
Normal plot of residuals deviated from ‘S-shaped’ curve pattern 
which suggested that % DL data need not any transformation [14]. 
fig. 6b illustrated the absence of constant error for % DL. Fig. 6c 
explored random and uniform scatter of externally studentized 
residuals for % DL. Fig. 6d manifested that actual values of % DL 
were in close agreement with predicted values. 
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Fig. 4: Diagnostic plot for mean particle size (a) normal probability plot (b) studentized residuals vs. predicted values plot (c) externally 
studentized residuals vs. run number plot and (d) predicted vs. actual values plot 
 
 
Fig. 5: Diagnostic plot for % process yield (a) normal probability plot (b) studentized residuals vs. predicted values plot (c) externally 
studentized residuals vs. run number plot and (d) predicted vs. actual values plot 
 
Response surface analysis 
Fig. 7a and 8a depicted effect of varying drug: polymer ratio and 
surfactant concentration on % EE (Y1) when stirring time, DP/CP 
ratio and stirring speed was kept steady. Fig. 7b and 8b illustrated 
influence of varying drug: polymer ratio and stirring time on % EE 
when surfactant concentration, DP/CP ratio and stirring speed were 
kept constant. Drug: polymer ratio (X1) and surfactant concentration 
(X2) indicated significant positive outcome on % EE. This can be due 
to tremendous amount of polymer available to drug and the 
increased viscosity of droplets [11, 30, 31]. Entrapment efficiency 
was significantly increased with an increase in surfactant 
concentration which can be due to stabilization of emulsion droplets 
by surfactant [32, 33]. Consequence of varying DP/CP ratio and 
drug: polymer ratio on % EE was analyzed when other factors were 
retained fixed as depicted in fig. 7c and 8c. 
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Fig. 6: Diagnostic plot for % drug loading (a) normal probability plot (b) studentized residuals vs. predicted values plot (c) externally 
studentized residuals vs. run number plot and (d) predicted vs. actual values plot 
 
 
Fig. 7: Response surface plot (3D) showing effect of operating conditions on % EE (Y1) 
 
DP/CP ratio (X4) had considerable positive effect on % EE. It had been demonstrated that % EE was remarkably high at medium level of DP/CP ratio 
due to availability of sufficient amount of CP with adequate viscosity. Effect of changing stirring speed and drug: polymer ratio on % EE (Y1) was 
explored as depicted in fig. 7d and 8d. Stirring speed (X5) had considerable positive impact on % EE. fig. 7e and 8e depicted effect of varying stirring 
speed and stirring time on % EE. fig. 7f and 8f demonstrated effect of varying DP/CP ratio and stirring time on % EE. 
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Fig. 8: Counter plot (2D) showing effect of operating conditions on % EE (Y1) 
 
Effect of transforming drug: polymer ratio (X1) and stirring time (X3) on mean particle size (Y2) was investigated (fig. 9a and 10a). Influence of modifying 
drug: polymer ratio (X1) and DP/CP ratio (X4) on mean particle size (Y2) was examined (fig. 9b and 10b). It was perceived that mean particle size 
increased rapidly with increasing drug: polymer ratio which can be illustrated by an increase in density of dispersed phase and size of droplets [11, 30, 
31]. Effect of varying drug: polymer ratio (X1) and stirring speed (X5) on mean particle size was analyzed (fig. 9c and 10c). Effect of varying stirring time 
(X3) and stirring speed (X5) on mean particle size was studied when other independent variables were retained constant (fig. 9e and 10e).  
 
 
Fig. 9: Response surface plot (3D) showing effect of operating conditions on mean particle size (Y2) 
Singh et al. 
Int J Pharm Pharm Sci, Vol 7, Issue 10, 89-101 
 
97 
It was noted that increase in stirring speed resulted in remarkable 
decrease in mean particle size which can be due to force exerted by 
high rpm that leads to reduction in particle size [11, 30, 31]. Effect of 
varying surfactant concentration (X2) and stirring speed (X5) on 
mean particle size was evaluated when drug: polymer ratio, stirring 
time and DP/CP ratio were kept constant (fig. 9d and 10d). It was 
observed that increase in surfactant concentration could efficiently 
reduce the particle size of nanospheres due to surfactant-induced 
reduction in surface tension between DP and CP which might 
stabilize newly generated surfaces and prevents particle aggregation 
[11, 32-34]. Fig. 9f and 10f demonstrated effect of varying DP/CP 
ratio (X4) and stirring speed (X5) on mean particle size when drug: 
polymer ratio, surfactant concentration and stirring time were kept 
constant. Results demonstrated that mean particle size decreased 
rapidly with increasing stirring speed because high rpm resulted in 
reduction of particle size [32, 33]. 
 
 
Fig. 10: Counter plot (2D) showing effect of operating conditions on mean particle size (Y2) 
 
Effect of altering drug: polymer ratio (X1) on % process yield (Y3) was reviewed. % process yield increased rapidly with increasing drug: polymer 
ratio (fig. 11a, 11b, 11c, 12a, 12b and 12c). Influence of modifying stirring time (X3), DP/CP ratio (X4) and surfactant concentration (X2) had no 
significant effect on % process yield as revealed in response surface graphs and counter plots (fig. 11 and 12). 
 
 
Fig. 11: Response surface plot (3D) showing effect of operating conditions on % process yield (Y3) 
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Fig. 12: Counter plot (2D) showing effect of operating conditions on % process yield (Y3) 
 
Effect of varying drug: polymer ratio (X1) on % DL (Y4) was explored 
and it was observed that % DL decreased rapidly with increasing 
drug: polymer ratio (fig. 13a, 13b, 13c, 14a, 14b and 14c). Influence 
of transforming drug: polymer ratio (X1) and stirring speed (X5) on 
% DL was investigated as depicted in fig. 13c and 14c. It was 
observed that % DL increased with increase in stirring speed.  
Effect of changing surfactant concentration (X2) and DP/CP ratio 
(X4) on % DL was examined (fig. 13d and 14d). It was noticed 
that % DL increased with increase in DP/CP ratio. Stirring time 
and surfactant concentration had non-significant effect on % DL 




Fig. 13: Response surface plot (3D) showing effect of operating conditions on % DL (Y4) 
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Fig. 14: Counter plot (2D) showing effect of operating conditions on % DL (Y4) 
 
 
Fig. 15: Counter plot (2D) showing desirability function for optimum formulation predicted by Design-Expert software 
 
 
Fig. 16: Response surface plot (3D) showing desirability function for optimum formulation predicted by Design-Expert software 
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Design-expert software developed optimization report which 
conclude that formulation prepared with 1:3 drug: polymer ratio 
(w/w), 2 % (w/v) surfactant, 3.8 h stirring time, 1:12 DP/CP ratio 
and 2000 rpm stirring speed was having highest desirability 
function of 0.920 (fig. 15 and 16). 
CONCLUSION 
Polyacrylate nanospheres of NFH were auspiciously fabricated by 
quasi solvent diffusion technique using 35 Box-Behnken design. This 
research work conclusively manifested that design of experiments 
(DoE) has been powerful, elegant and cost-effective statistical 
technique which yields more information from fewest runs. 
Standardized pareto chart elucidated that drug: polymer ratio (X1) 
and stirring speed (X5) was substantial factors with p<0.05 affecting 
response characteristics of nanospheres. Significant model F-value 
(p<0.05) and non-significant lack of fit F-value (p>0.05) for response 
variables exemplified accuracy of data. Adjusted R-squared and 
predicted R-squared indicated rational agreement between 
regression coefficients. Smaller PRESS value for regression models 
indicated good fit of model. Adequate precision (AP) value indicated 
adequate model discrimination and concluded that models can be 
used to navigate design space.  
Normal probability plots proved normality of response data. 
Externally studentized residuals vs. predicted values of response 
parameters revealed absence of constant error. Residual vs. run 
number plot explored absence of lurking variables. Predicted vs. 
actual values plot revealed that actual values of response 
parameters were in close agreement with predicted values. 
Contour plot or response surface plot showed effect of various 
operating conditions on response parameters in 2-D and 3-D, 
respectively. It was concluded that X1, X2, X4 and X5 had the 
significant positive effect on % EE. X1 and X5 produced significant 
synergistic and antagonistic effect on mean particle size, 
respectively. X1 and X5 furnished significant positive effect on % 
process yield. X1 produced remarkable antagonistic effect on % DL 
while X4 and X5 exhibited synergistic effect on % DL. Optimization 
report concluded that formulation prepared with 1:3 drug: 
polymer ratio (w/w), 2% (w/v) surfactant, 3.8 h stirring time, 
1:12 DP/CP ratio and 2000 rpm stirring speed was having highest 
desirability function of 0.920.  
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